Meld u aan

Alexandros Kiriazis

Drug Research Program,
Division of Pharmaceutical Chemistry and Technology,
Faculty of Pharmacy,
Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy

University of Helsinki

BIOGRAPHY

Alexandros Kiriazis has not added Biography.

If you are Alexandros Kiriazis and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Enzyme-assisted synthesis and characterization of glucuronide conjugates of neuroactive steroids.

Steroids Mar, 2007 | Pubmed ID: 17250861

Stereoselective aza Diels-Alder reaction on solid phase: a facile synthesis of hexahydrocinnoline derivatives.

Journal of combinatorial chemistry Mar-Apr, 2007 | Pubmed ID: 17348732

Enzyme-assisted synthesis and structure characterization of glucuronic acid conjugates of losartan, candesartan, and zolarsartan.

Bioorganic chemistry Jun, 2008 | Pubmed ID: 18378273

Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives.

Bioorganic & medicinal chemistry Feb, 2010 | Pubmed ID: 20116263

Tricyclic Benzo[cd]azulenes selectively inhibit activities of Pim kinases and restrict growth of Epstein-Barr virus-transformed cells.

PloS one , 2013 | Pubmed ID: 23405147

In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells.

Biomaterials 03, 2017 | Pubmed ID: 28081462

Nucleophilic Substitution of Hydrogen Facilitated by Quinone Methide Moieties in Benzo[cd]azulen-3-ones.

Organic letters 04, 2017 | Pubmed ID: 28379712

Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs.

Nanomedicine (London, England) Nov, 2017 | Pubmed ID: 28960138

Preparation and Characterization of Dentin Phosphophoryn-Derived Peptide-Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake.

Small (Weinheim an der Bergstrasse, Germany) Jun, 2019 | Pubmed ID: 31062448

Asymmetry in catalysis by membrane-bound pyrophosphatase demonstrated by a nonphosphorus allosteric inhibitor.

Science advances May, 2019 | Pubmed ID: 31131322

INSTITUTIONS

University of Helsinki

JOVE ARTICLES

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Keni Vidilaseris^*,1,

Niklas G. Johansson^*,2,

Ainoleena Turku²,

Alexandros Kiriazis²,

Gustav Boije af Gennäs²,

Jari Yli-Kauhaluoma²,

Henri Xhaard²,

Adrian Goldman^1,3

¹Research Program in Molecular and Integrative Biosciences, University of Helsinki,

²Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki,

³School of Biomedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds

Biochemistry

Privacy

Gebruiksvoorwaarden

Beleid

Neem contact met ons op.

Aanbevelen aan bibliotheek

JoVE Nieuwsbrieven

Onderzoek

JoVE Journal
Methoden Collecties
JoVE Encyclopedia of Experiments
Archiveren

Onderwijs

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Faculteitssite

Auteurs

Overzicht
Publicatieproces
Redactieraad
Omvang en beleid
Collegiale beoordeling
VEELGESTELDE VRAGEN
Verzenden

Bibliothecarissen

Overzicht
Getuigenissen
Abonnementen
Toegang
Middelen
Bibliotheek Adviesraad
VEELGESTELDE VRAGEN

Over JoVE

Overzicht
Leiderschap
Blog
JoVE Help Center
JoVE Sitemap

Alexandros Kiriazis

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Drug Research Program,Division of Pharmaceutical Chemistry and Technology,Faculty of Pharmacy,Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy

University of Helsinki

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Drug Research Program,
Division of Pharmaceutical Chemistry and Technology,
Faculty of Pharmacy,
Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy